Search

Search Constraints

You searched for: Author/Creator Mackey, Howard

Search Results

1. The Alzheimer's Prevention Initiative Autosomal‐Dominant Alzheimer's Disease Trial: A study of crenezumab versus placebo in preclinical PSEN1 E280A mutation carriers to evaluate efficacy and safety in the treatment of autosomal‐dominant Alzheimer's disease, including a placebo‐treated noncarrier cohort. Issue 1 (8th March 2018)

2. P1‐046: BASELINE CHARACTERISTICS FROM CREAD2: A PHASE III TRIAL OF CRENEZUMAB IN EARLY (PRODROMAL‐TO‐MILD) ALZHEIMER'S DISEASE. (1st July 2019)

3. O1‐02‐04: BASELINE CHARACTERICS FROM A PHASE 3 TRIAL OF CRENEZUMAB IN PRODROMAL TO MILD ALZHEIMER'S DISEASE (CREAD). (1st July 2006)

4. P4‐014: ESTIMAND IN EARLY ALZHEIMER'S DISEASE: PROGRESS UPDATE FROM THE INTERNATIONAL ALZHEIMER'S DISEASE SCIENTIFIC WORKING GROUP (AD SWG) SUBSTREAM. (1st July 2006)

7. Baseline demographic, clinical, and cognitive characteristics of the Alzheimer's Prevention Initiative (API) Autosomal‐Dominant Alzheimer's Disease Colombia Trial. Issue 7 (17th May 2020)